Tango Therapeutics, Inc.
TNGX
$6.61
$0.111.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.06% | -5.17% | -22.45% | -31.01% | -23.38% |
| Total Depreciation and Amortization | -1.11% | -0.48% | 0.49% | 1.47% | 4.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.98% | 20.92% | 120.18% | 6.14% | 41.92% |
| Change in Net Operating Assets | 13.92% | -46.63% | -852.93% | 26.47% | 37.03% |
| Cash from Operations | -54.70% | -10.14% | -33.42% | -7.24% | 3.54% |
| Capital Expenditure | -95.00% | 73.85% | 45.13% | -618.75% | 51.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 33.67% | 378.42% | 53.13% | 157.70% | -60.96% |
| Cash from Investing | 32.12% | 373.11% | 53.79% | 157.48% | -61.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -55.68% | -100.00% | -43.27% | -97.01% | 123.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -55.68% | -100.00% | -33.95% | -97.01% | 123.72% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.65% | -82.59% | 108.63% | 121.04% | -209.06% |